Truist Financial Corp Grows Stock Position in Humana Inc. $HUM

Truist Financial Corp boosted its holdings in Humana Inc. (NYSE:HUM) by 102.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,334 shares of the insurance provider’s stock after acquiring an additional 4,723 shares during the period. Truist Financial Corp’s holdings in Humana were worth $2,428,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Fisher Funds Management LTD boosted its stake in Humana by 43.1% during the third quarter. Fisher Funds Management LTD now owns 79,282 shares of the insurance provider’s stock worth $20,627,000 after buying an additional 23,867 shares during the period. Rakuten Investment Management Inc. purchased a new position in shares of Humana during the 3rd quarter worth approximately $10,823,000. Ethic Inc. increased its holdings in Humana by 174.3% in the 3rd quarter. Ethic Inc. now owns 9,575 shares of the insurance provider’s stock valued at $2,491,000 after purchasing an additional 6,084 shares during the last quarter. Teacher Retirement System of Texas raised its position in Humana by 12.5% in the third quarter. Teacher Retirement System of Texas now owns 63,332 shares of the insurance provider’s stock valued at $16,477,000 after purchasing an additional 7,046 shares during the period. Finally, Bank of Nova Scotia boosted its position in shares of Humana by 219.3% during the second quarter. Bank of Nova Scotia now owns 242,385 shares of the insurance provider’s stock worth $59,258,000 after buying an additional 166,475 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on HUM. Bank of America increased their target price on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Robert W. Baird reduced their price target on shares of Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a research report on Thursday, December 11th. Zacks Research lowered shares of Humana from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 1st. KeyCorp reaffirmed a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Finally, Wolfe Research raised their price target on shares of Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a research report on Thursday, January 8th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $293.21.

Humana Stock Up 0.2%

Shares of NYSE:HUM opened at $193.91 on Friday. Humana Inc. has a fifty-two week low of $186.00 and a fifty-two week high of $315.35. The firm’s 50 day moving average price is $251.55 and its 200 day moving average price is $262.65. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. The stock has a market cap of $23.32 billion, a price-to-earnings ratio of 18.17, a price-to-earnings-growth ratio of 1.60 and a beta of 0.44.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter in the previous year, the business posted $4.16 EPS. The firm’s revenue was up 11.1% on a year-over-year basis. As a group, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.